A Promising New Way to Prevent HIV Infections
Why a new injectable drug is a breakthrough, and how Canadian scientists are improving access to it.
News
Read more
Long-acting injectable PrEP is a big step forward in HIV prevention
One year ago, the United States approved a new injectable drug that prevents HIV.
WHO recommends long-acting cabotegravir for HIV prevention
New WHO guidelines advise countries to deliver long-acting cabotegravir as part of comprehensive approach to HIV prevention
ViiV healthcare and the medicines patent pool sign new voluntary licensing agreement to expand access to innovative long-acting hiv prevention medicine
Cabotegravir LA for PrEP is a long-acting injectable which has recently gained its first regulatory approval for use in HIV prevention in the USA for…
Una inyeccion de efecto prolongado ayudara a prevenir el VIH en Brasil y Sudafrica – ONU Noticias
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention
Drug Given Every Two Months Rather Than Daily Pill is Important Tool in Effort to End the HIV Epidemic